NASDAQ:FULC - Nasdaq - US3596161097 - Common Stock - Currency: USD
Overall FULC gets a fundamental rating of 4 out of 10. We evaluated FULC against 197 industry peers in the Pharmaceuticals industry. FULC has a great financial health rating, but its profitability evaluates not so good. FULC is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -3.73% | ||
ROE | -4% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | 11 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 22.63 | ||
Quick Ratio | 22.63 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:FULC (5/29/2025, 9:37:02 AM)
7.015
+0.11 (+1.67%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 4.73 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.56 | ||
P/tB | 1.56 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -3.73% | ||
ROE | -4% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 17.45% | ||
Cap/Sales | 0.35% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 22.63 | ||
Quick Ratio | 22.63 | ||
Altman-Z | 11 |